Warren Buffett called out Elizabeth Holmes' Theranos for prizing big names over experts - a key issue at the blood-testing startup
Warren Buffettcalled out Theranosfor appointing political and military leaders to its board.
- The investor looks for business-savvy directors who care about shareholders and his company.
- Theranos founder
Elizabeth Holmesprioritized public image over effective technology, critics say.
Warren Buffett diagnosed an issue at Theranos that was symptomatic of a major problem at the company.
The famed investor and Berkshire Hathaway CEO called out Elizabeth Holmes'
"They got some very big names on their board," Buffett said. In contrast, Berkshire isn't interested in directors who expect a ton of money for 10% of their time, or who want the role because it's prestigious and they want to check a box on their résumé, he continued.
Instead, Buffett's company looks for board members who are business savvy, shareholder-oriented, and have a strong personal interest in Berkshire, he said.
"We want our directors to walk in the shoes of our shareholders," Buffett said. "We want them to care a lot about the business, and we want them to be smart enough so they know what they should get involved in, and what they shouldn't get involved in," he added.
Charlie Munger, Buffett's longtime business partner and Berkshire's vice-chairman, echoed the view that boards should hire the best people for the job. He told an anecdote about the Roman Catholic Archbishop of Los Angeles once hiring Munger's law firm instead of a Catholic lawyer. The archbishop explained the decision by noting that when he had to choose a doctor to perform a major surgery on him the previous year, he didn't go out looking for a Catholic surgeon.
"That's the way I feel about board members," Munger said.
Theranos was privately valued at $9 billion at its peak, but collapsed after The Wall Street Journal reported its blood-testing machines weren't reliable and the company had given inaccurate blood-test results to patients, spurring multiple investigations into the business.
Buffett's comments suggest he believes Holmes' focus was on linking the Theranos brand to high-profile individuals who could lend credibility to her company - not securing the counsel of medical or business experts. That fits with the prosecution's claims that she cared more about her company's public image and winning over investors than she did about whether its technology worked.
Theranos didn't immediately respond to a request for comment from Insider.
- A 29-year-old woman found a mark on her head and was diagnosed with a fungal infection. It turned out to be invasive skin cancer.
- JPMorgan CEO Jamie Dimon told wealthy clients there's a chance the US is heading into 'something worse' than a recession, report says
- Why Google employees fear the worst as the company quietly extends its hiring freeze
- Nepotism and termite-like corruption dented India : Modi
- Modi lists five pledges to turn India into a developed country in 25 years
- There will be a major shift in the way Indians shop and consume brands
- Modi remembers Nehru and Sarvarkar in his speech today
- Made-in-India gun used for 1st time for ceremonial salute at Red Fort on Independence Day